# OnCo record dnx-2440 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dnx-2440/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dnx-2440" ;
  schema:name "DNX-2440"@en ;
  schema:description "DNX-2440 is an experimental oncolytic adenovirus from DNAtrix, in phase 1 trials for colorectal cancer liver metastases, liver metastases from other solid tumours and recurrent glioblastoma; development is paused."@en ;
  schema:url <https://onco.cc/drugs/dnx-2440/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.biospace.com/dnatrix-announces-first-patient-dosed-in-clinical-study-of-dnx-2440-an-ox40-ligand-expressing-immunotherapy-in-colorectal-cancer-and-other-cancers-with-liver-metastasis>, <https://clinicaltrials.gov/api/v2/studies/NCT04714983>, <https://clinicaltrials.gov/search?intr=DNX-2440> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oncolytic adenovirus" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:companies <https://onco.cc/companies/dnatrix/> ;
  onco:trials <https://onco.cc/trials/nct04714983/>, <https://onco.cc/trials/nct03714334/> .